[1]黄蝶 梁伟.血管衰老与老年心血管疾病相关性的研究进展[J].心血管病学进展,2024,(5):412.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.007]
　HUANG Die,LIANG Wei.The Correlation Between Vascular Aging and Elderly Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2024,(5):412.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.007]
点击复制

血管衰老与老年心血管疾病相关性的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年5期
页码:
412
栏目:
综述
出版日期:
2024-05-25

文章信息/Info

Title:
The Correlation Between Vascular Aging and Elderly Cardiovascular Disease
作者:
黄蝶1; 2 梁伟 1
(1.上海交通大学医学院附属瑞金医院老年科,上海200025;2.上海市浦东新区北蔡社区卫生服务中心全科,上海 201204)
Author(s):
HUANG Die1; 2; LIANG Wei1
(1.Department of Geriatrics,Ruijin Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200025,China; 2.Department of General Practice,Beicai Community Health Service Center,Pudong New Area,Shanghai 201204,China)
关键词:
血管衰老; 老年; 心血管疾病
Keywords:
Vascular aging;  Old age;  Cardiovascular disease
DOI:
10.16806/j.cnki.issn.1004-3934.2024.05.007
摘要:
血管衰老指由于年龄、环境、炎症刺激等因素导致血管结构重构和功能减退的过程，是引起老年人心血管疾病发生的重要因素。现通过对血管衰老的主要发生机制（端粒损耗、线粒体功能障碍、氧化应激、炎症反应、肾素-血管紧张素-醛固酮系统和表观遗传学）进行概述，并针对血管衰老及其机制与老年心血管疾病的相关性进行综述，探讨血管衰老在老年心血管疾病中的作用。展望未来通过对血管衰老机制中参与老年心血管疾病的关键信号分子、传导通路和调控方式等的更深入研究，为延缓血管衰老、防治老年心血管疾病提供更多可能性。
Abstract:
Vascular aging refers to the process of structural remodeling and functional decline of the vasculature due to age ,environment and inflammatory stimuli,which is an important factor contributing to the development of cardiovascular disease in the elderly. In this paper,we explore the role of vascular aging in cardiovascular disease in the elderly by providing an overview of the main mechanisms involved in the occurrence of vascular senescence (telomere depletion ,mitochondrial dysfunction,oxidative stress,inflammatory response,renin-angiotensin-aldosterone system and epigenetics) and by providing an overview of vascular aging and its mechanisms in terms of their relevance to cardiovascular disease in the elderly. Looking ahead to the future,through more in-depth research on key signaling molecules,conduction pathways,and regulatory modes involved in the mechanism of vascular aging in elderly cardiovascular disease,more possibilities will be provided for delaying vascular aging and preventing and treating elderly cardiovascular disease.

参考文献/References:

[1] Wang S,Hu S,Mao Y. The mechanisms of vascular aging[J]. Aging Med(Milton),2021,4(2):153-158.

[2] Jamil A,Habib S. Delaying vascular aging:a new prospect in medicine[J]. EXCLI J,2019,18:1092-1093.

[3] Donato AJ,Walker AE,Garrett Morgan R,et al. Cellular and molecular biology of aging endothelial cells[J]. J Mol Cell Cardiol,2015,89(Pt B):122-135.

[4] 邓丽玉,洪华山. 血管衰老与血流动力学衰老综合征及其靶器官损害的研究进展[J]. 中华老年心脑血管病杂志,2023,25(1):102-104.

[5] 张存泰,陶军,田小利,等. 血管衰老临床评估与干预中国专家共识(2018)[J]. 中华老年病研究电子杂志,2019,6(1):1-8.

[6] Shay JW,Wright WE. Telomeres and telomerase:three decades of progress[J]. Nat Rev Genet,2019,20(5):299-309.

[7] Mir SM,Tehrani SS,Goodarzi G,et al. Shelterin complex at telomeres:implications in ageing[J]. Clin Interv Aging,2020,15:827-839.

[8] Graf M,Bonetti D,Lockhart A,et al. Telomere length determines TERRA and R-loop regulation through the cell cycle[J]. Cell,2017,170(1):72-85.

[9] Wang J,Toan S,Zhou H. New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury[J]. Angiogenesis,2020,23(3):299-314.

[10] 闫明静,沈涛. 线粒体功能障碍与血管内皮损伤的研究进展[J]. 中国动脉硬化杂志,2021,29(10):829-837.

[11] Salnikova D,Orekhova V,Grechko A,et al. Mitochondrial dysfunction in vascular w all cells and its role in atherosclerosis[J]. Int J Mol Sci,2021,22(16):8990.

[12] Kuczyńska M,Jakubek P,Bartoszek A. More than just antioxidants:redox-active components and mechanisms shaping redox signalling network[J]. Antioxidants(Basel),2022,11(12):2403.

[13] Steven S,Frenis K,Oelze M,et al. Vascular inflammation and oxidative stress:major triggers for cardiovascular disease[J]. Oxid Med Cell Longev,2019,2019:7092151.

[14] Han X,Lei Q,Xie J,et al. Potential regulators of the senescence-associated secretory phenotype during senescence and aging[J]. J Gerontol A Biol Sci Med Sci,2022,77(11):2207-2218.

[15] 徐舜,崔红晶,赵炜,等. 细胞衰老分子机制的研究进展[J]. 广东医科大学学报,2020,38(1):1-10.

[16] Whitcomb J,Gharibeh L,Nemer M. From embryogenesis to adulthood:critical role for GATA factors in heart development and function[J]. IUBMB Life,2020,72(1):53-67.

[17] 李公豪,徐良成,赵艳丽,等. 血管紧张素Ⅱ在心血管疾病动物模型构建中的应用进展[J]. 国际心血管病杂志,2023,50(2):99-103.

[18] Jin J,Liu Y,Huang L,et al. Advances in epigenetic regulation of vascular aging[J]. Rev Cardiovasc Med,2019,20(1):19-25.

[19] Zhang W,Song M,Qu J,et al. Epigenetic modifications in cardiovascular aging and diseases[J]. Circ Res,2018,123(7):773-786.

[20] Buford TW. Hypertension and aging[J]. Ageing Res Rev,2016,26:96-111.

[21] 杨明,谢文辉,洪华山. 重视血管衰老机制在高血压发生发展中的作用及其干预研究[J]. 中华高血压杂志,2023,31(8):701-704

[22] Spronck B,Obeid MJ,Paravathaneni M,等. 经血压.校正的动脉僵硬度指标的预测价值：脉搏波传导速度、心踝血管指数与血压校正的心踝血管指数的比较[J]. 中华高血压杂志,2023,31(3):272-280.

[23] Wu S,Jin C,Li S,et al. Aging,arterial stiffness,and blood p ressure association in Chinese adults[J]. Hypertension,2019,73(4):893-899.

[24] Boutouyrie P,Chowienczyk P,Humphrey J,et al. Arterial stiffness and cardiovascular risk in hypertension[J]. Circ Res,2021,128(7):864-886.

[25] Meng Y,Buscot MJ,Juonala M,et al. Relative contribution of blood pressure in childhood,young- and mid-adulthood to large artery stiffness in mid-adulthood[J]. J Am Heart Assoc,2022,11(12):e024394.

[26] Laurent S,Chatellier G,Azizi M,et al. SPARTE study:normalization of arterial stiffness and cardiovascular events in p atients with hypertension at medium to very high risk[J]. Hypertension,2021,78(4):983-995.

[27] Picone D,Schultz M,Otahal P,et al. Influence of age on upper arm cuff blood pressure measurement[J]. Hypertension,2020,75(3):844-850.

[28] Ji H,Kwan A,Chen M,et al. Sex differences in myocardial and vascular aging[J]. Circ Res,2022,130(4):566-577.

[29] Ungvari Z,Tarantini S,Sorond F,et al. Mechanisms of vascular aging,a geroscience perspective:JACC focus seminar[J]. J Am Coll Cardiol,2020,75(8):931-941.

[30] Abdellatif M,Rainer PP,Sedej S,et al. Hallmarks of cardiovascular ageing[J]. Nat Rev Cardiol,2023,20(11):754-777.

[31] 袁蓉,信琪琪,施伟丽,等. 血管衰老加剧动脉粥样硬化主要机制及中医药干预作用[J]. 中国中西医结合杂志,2023,43(5):627-631.

[32] Zernecke A,Winkels H,Cochain C,et al. Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas[J]. Circ Res,2020,127(3):402-426.

[33] Engelen S,Robinson A,Zurke Y,et al. Therapeutic strategies targeting inflammation and immunity in atherosclerosis:how to proceed?[J]. Nat Rev Cardiol,2022,19(8):522-542.

[34] Ridker P,Everett B,Thuren T,et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease[J]. N Engl J Med,2017,377(12):1119-1131.

[35] Ridker P,Devalaraja M,Baeres F,et al. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk(RESCUE):a double-blind,randomised,placebo-controlled,phase 2 trial[J]. Lancet,2021,397(10289):2060-2069.

[36] Bloom S,Tucker J,Lim J,et al. Aging results in DNA damage and telomere dysfunction that is greater in endothelial versus vascular smooth muscle cells and is exacerbated in atheroprone regions[J]. Geroscience,2022,44(6):2741-2755.

[37] Garrido A,Kaistha A,Uryga A,et al. Efficacy and limitations of senolysis in atherosclerosis[J]. Cardiovasc Res,2022,118(7):1713-1727.

[38] Kornej J,B?rschel CS,Benjamin E,et al. Epidemiology of atrial fibrillation in the 21st century:novel methods and new insights[J]. Circ Res,2020,127(1):4-20.

[39] Qin S,Boidin M,Buckley B,et al. Endothelial dysfunction and vascular maladaptation in atrial fibrillation[J]. Eur J Clin Invest,2021,51(5):e13477.

[40] Roberts J,Vittinghoff E,Lu A,et al. Epigenetic age and the risk of incident atrial fibrillation[J]. Circulation,2021,144(24):1899-1911.

相似文献/References:

[1]司晓云 周纬 谌晶晶 莫显刚 王龙 段小容.希氏束起搏与右室心尖部起搏对老年患者心功能影响的对比分析[J].心血管病学进展,2019,(7):1052.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.022]
　SI Xiaoyun ZHOU W eiSHEN JingjingMO XiangangWANG LongDUAN Xiaorong.A Comparative Study of Cardiac Function between Hirschner Bundle Pacing and Right Ventricular Aapex Pacing in Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(5):1052.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.022]
[2]李可 田进文 邓珏琳.老年高血压的临床诊治研究进展[J].心血管病学进展,2019,(9):1208.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.006]
　LI Ke,TIAN Jinwen,DENG Juelin.Diagnosis and Treatment in Elderly Hypertension[J].Advances in Cardiovascular Diseases,2019,(5):1208.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.006]
[3]侯利莎 葛宁 赵艳莉 张蒙 谢冬梅 高浪丽 岳冀蓉 郑玉霞.老年营养风险指数对老年高血压住院患者发生谵妄的预测价值[J].心血管病学进展,2020,(7):765.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.022]
　HOU Lisha,GE Ning,ZHAO Yanli,et al.Value of Geriatric Nutritional Risk Index in Predicting Risk of Delirium among Elderly Hypertension Patients[J].Advances in Cardiovascular Diseases,2020,(5):765.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.022]
[4]王君 蔡琳.老年人共病与非ST段抬高型急性冠脉综合征研究进展[J].心血管病学进展,2023,(9):837.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.016]
　WANG Jun,CAI Lin.Older Adults with Comorbidity and Non-ST-Segment Elevation A cute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2023,(5):837.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.016]

更新日期/Last Update: 2024-06-28